HCW Biologics Inc. (HCWB)

NASDAQ

$2.09

$+0.59

(+35.54%)

Regular Market

HCW Biologics Inc. (HCWB) Live Price Chart

Last updated: ⁦2026-09-24 15:38:40⁩. Prices reflect the latest regular market data. Stock price data is sourced from Massive.

Summary

HCW Biologics Inc. (HCWB) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $2.09, with a market capitalization of $3.32M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1.41 to $29.28. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$3.32M
Open	$1.69
Day's High	$1,866.00
Day's Low	$1.41
Previous Close	$1.66
Volume	11.38M
Average Volume	161.79K
P/E Ratio	--
52-Week High	$29.28
52-Week Low	$1.41
Dividend Yield	--
Earnings Date	--

HCW Biologics Inc. (HCWB) Stock Price Today

HCW Biologics Inc. (HCWB) is currently trading at $2.09 as of 2026-09-24 15:22:55, up 25.84% ($0.43) from the previous close of $1.66

During today's regular trading session, HCWB has traded between $1.41 and $1,866.00, with a trading volume of 11.38M shares. The current price is near the lower end of today's range.

HCW Biologics Inc. (HCWB) 7-Day Stock Price Change

Over the past seven days, HCW Biologics Inc. (HCWB) moved from $2.05 to $2.09, representing a gain of 1.90% ($0.04).

The stock traded between $1.41 and $2.77 during the period. The latest price is near the middle of the 7-day range, indicating moderate upward.

The average daily volume was 93.08 thousand shares, down versus the previous seven-day period, indicating lower trading activity.

HCWB 52-Week Price Position

Position in Range: 2.5%

52W Low$1.41

52W High$29.28

HCWB is currently trading at $2.09, placing it 2.5% of the way from its 52-week low of $1.41 to its 52-week high of $29.28. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is HCW Biologics Inc. (HCWB)?

HCW Biologics Inc is a clinical-stage biopharmaceutical company developing transformative fusion immunotherapeutics to support or treat diseases promoted by chronic inflammation. It has created novel compounds that represent a new class of drugs that it believes has the potential to fundamentally change the treatment of autoimmune disorders and other proinflammatory diseases, cancer and senescence-associated dysplasia. The company has developed two proprietary drug discovery and development platforms which it uses to create novel fusion immunotherapeutics: The TOBI (Tissue factOr-Based fusIon) platform, and The T-cell Receptor Beta Chain constant region (TRBC) platform. It operates and manages its business as one reportable segment.

HCW Biologics Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	35
Exchange	NASDAQ
Company Website	https://www.hcwbiologics.com

How to Buy HCW Biologics Inc. (HCWB) Stock on MEXC

Eligible investors can buy real shares of HCW Biologics Inc. (HCWB) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for HCWB and Place Your Order

Open the RealStocks trading page and search for HCWB. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is HCW Biologics Inc. (HCWB) stock price today?

HCW Biologics Inc. (HCWB) is currently trading at $ 2.09, up 25.84% ($0.43) from the previous close of $ 1.66. Intraday prices update in real time during regular trading hours.

2.Is HCWB stock going up or down today?

As of 2026-09-24 15:22:55, HCWB is trading at $ 2.09, up 25.84% ($0.43) from its previous close of $ 1.66. The stock has traded between $ 1.41 and $ 1,866.00 during today’s regular session. Past price movements do not guarantee future results.

3.What is HCWB pre-market price?

As of 2026-09-24 15:22:55, HCWB is trading at $ 1.68 in pre-market trading, up 1.20% ($0.02) from the previous close of $ 1.66. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is HCWB after-hours price?

As of 2026-09-24 15:22:55, HCWB is trading at $ 1.75 in after-hours trading, up 5.42% ($0.09) from the regular-session close of $ 1.66. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is HCWB stock trading now?

HCWB trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does HCWB sit relative to its 52-week high and low?

Over the past 52 weeks, HCWB has traded between a low of $ 1.41 and a high of $ 29.28. At $ 2.09, the stock is positioned 2.5% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is HCW Biologics Inc. in?

HCW Biologics Inc. (HCWB) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is HCW Biologics Inc.'s market capitalization and where is it listed?

HCW Biologics Inc. is listed on the NASDAQ exchange with a market capitalization of $ 3.32M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is HCWB valued in terms of P/E ratio and EPS?

HCWB trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -11.66. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does HCW Biologics Inc. pay a dividend?

HCW Biologics Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.